Back
Taysha Gene Therapies Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Sell
48
TSHA
Taysha Gene Therapies
Last Price:
$2.55
Seasonality Move:
81.2%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
The current trend is moderately bearish and TSHA is experiencing slight selling pressure.
Taysha Gene Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.72 | Sell |
| 20-day SMA: | 2.74 | Sell |
| 50-day SMA: | 2.15 | Buy |
| 200-day SMA: | 1.98 | Buy |
| 8-day EMA: | 2.67 | Sell |
| 20-day EMA: | 2.63 | Sell |
| 50-day EMA: | 2.33 | Buy |
| 200-day EMA: | 2.07 | Buy |
Taysha Gene Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | -821264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.46 - 2.86) | Sell |
| Bollinger Bands (100): | (1.38 - 2.4) | Buy |
Taysha Gene Therapies Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Taysha Gene Therapies Stock
Is Taysha Gene Therapies Stock a Buy?
-
Taysha Gene Therapies share price is 2.54 while TSHA 8-day simple moving average is 2.72, which is a Sell signal.
-
The stock price of TSHA is 2.54 while Taysha Gene Therapies 20-day SMA is 2.74, which makes it a Sell.
-
Taysha Gene Therapies 50-day simple moving average is 2.15 while TSHA share price is 2.54, making it a Buy technically.
-
TSHA stock price is 2.54 and Taysha Gene Therapies 200-day simple moving average is 1.98, creating a Buy signal.
TSHA Technical Analysis vs Fundamental Analysis
Sell
48
Taysha Gene Therapies (TSHA)
is a Sell
Is Taysha Gene Therapies a Buy or a Sell?
-
Taysha Gene Therapies stock is rated a SellThe current Taysha Gene Therapies [TSHA] share price is $2.54. The Score for TSHA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Taysha Gene Therapies Stock Info
Market Cap:
545.2M
Price in USD:
2.54
Share Volume:
2.5M
Taysha Gene Therapies 52-Week Range
52-Week High:
4.32
52-Week Low:
1.05
Sell
48
Taysha Gene Therapies (TSHA)
is a Sell
Taysha Gene Therapies Share Price Forecast
-
What is the Taysha Gene Therapies stock price today?The Taysha Gene Therapies stock price is 2.54 USD today.
-
Will TSHA stock go up or go down?Taysha Gene Therapies> share price is forecast to RISE/FALL based on technical indicators
-
Is Taysha Gene Therapies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Taysha Gene Therapies is overvalued.
Is Taysha Gene Therapies Stock a Buy?
-
Taysha Gene Therapies share price is 2.54 while TSHA 8-day exponential moving average is 2.67, which is a Sell signal.
-
The stock price of TSHA is 2.54 while Taysha Gene Therapies 20-day EMA is 2.63, which makes it a Sell.
-
Taysha Gene Therapies 50-day exponential moving average is 2.33 while TSHA share price is 2.54, making it a Buy technically.
-
TSHA stock price is 2.54 and Taysha Gene Therapies 200-day simple moving average is 2.07, creating a Buy signal.
Fundamental Analysis of Taysha Gene Therapies
Is Taysha Gene Therapies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.02 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Taysha Gene Therapies
Should I short Taysha Gene Therapies stock?
-
TSHA Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Taysha Gene Therapies is a Buy
-
Taysha Gene Therapies Relative Strength Index (RSI) is 49.51, which suggest Taysha Gene Therapies is oversold
-
The Bollinger Bands (25) for Taysha Gene Therapies is (2.46 - 2.86), which suggest Taysha Gene Therapies is a Buy
-
The Bollinger Bands (100) for Taysha Gene Therapies is (1.38 - 2.4), which suggest Taysha Gene Therapies is a Buy
* Taysha Gene Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.